Bath & Body Works (NYSE:BBWI) Stock Rating Reaffirmed by BMO Capital Markets

BMO Capital Markets reaffirmed their outperform rating on shares of Bath & Body Works (NYSE:BBWI) in a report released on Thursday, Benzinga reports. BMO Capital Markets currently has a $50.00 price objective on the stock, down from their prior price objective of $52.00.

Other equities research analysts have also issued reports about the stock. Deutsche Bank Aktiengesellschaft lowered their price target on shares of Bath & Body Works from $57.00 to $54.00 and set a buy rating on the stock in a research note on Monday. UBS Group decreased their price objective on shares of Bath & Body Works from $52.00 to $38.00 and set a neutral rating for the company in a research report on Thursday. The Goldman Sachs Group decreased their price objective on shares of Bath & Body Works from $60.00 to $49.00 and set a buy rating for the company in a research report on Thursday. Evercore ISI decreased their price objective on shares of Bath & Body Works from $45.00 to $35.00 and set an in-line rating for the company in a research report on Wednesday. Finally, Bank of America decreased their price objective on shares of Bath & Body Works from $54.00 to $45.00 and set a buy rating for the company in a research report on Thursday. Eight investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat, the company has an average rating of Moderate Buy and a consensus price target of $42.50.

Bath & Body Works Trading Down 4.0 %

Shares of BBWI stock opened at $31.01 on Thursday. Bath & Body Works has a 1 year low of $27.30 and a 1 year high of $52.99. The firm’s fifty day moving average price is $35.68 and its two-hundred day moving average price is $42.68. The firm has a market capitalization of $6.92 billion, a P/E ratio of 7.99, a PEG ratio of 1.16 and a beta of 1.85.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.02. Bath & Body Works had a net margin of 11.92% and a negative return on equity of 40.00%. The firm had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.54 billion. As a group, equities research analysts forecast that Bath & Body Works will post 3.29 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, September 6th. Investors of record on Friday, August 23rd will be issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 2.58%. The ex-dividend date is Friday, August 23rd. Bath & Body Works’s payout ratio is 20.62%.

Institutional Trading of Bath & Body Works

Hedge funds and other institutional investors have recently bought and sold shares of the business. GAMMA Investing LLC acquired a new stake in Bath & Body Works in the 4th quarter worth about $27,000. First Community Trust NA acquired a new stake in Bath & Body Works in the 2nd quarter worth about $30,000. EverSource Wealth Advisors LLC raised its stake in Bath & Body Works by 72.0% in the 4th quarter. EverSource Wealth Advisors LLC now owns 805 shares of the company’s stock worth $35,000 after purchasing an additional 337 shares in the last quarter. EntryPoint Capital LLC raised its stake in Bath & Body Works by 224.0% in the 1st quarter. EntryPoint Capital LLC now owns 1,471 shares of the company’s stock worth $74,000 after purchasing an additional 1,017 shares in the last quarter. Finally, Federated Hermes Inc. raised its stake in Bath & Body Works by 17.1% in the 4th quarter. Federated Hermes Inc. now owns 1,612 shares of the company’s stock worth $70,000 after purchasing an additional 235 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.